Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to $113026.0.

  • Evoke Pharma's Non-Current Assets fell 213.18% to $113026.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $668456.0, marking a year-over-year increase of 8717.7%. This contributed to the annual value of $281110.0 for FY2024, which is 1633.57% up from last year.
  • According to the latest figures from Q3 2025, Evoke Pharma's Non-Current Assets is $113026.0, which was down 213.18% from $129250.0 recorded in Q2 2025.
  • In the past 5 years, Evoke Pharma's Non-Current Assets registered a high of $281110.0 during Q4 2024, and its lowest value of $12428.0 during Q4 2021.
  • For the 5-year period, Evoke Pharma's Non-Current Assets averaged around $115489.3, with its median value being $115488.0 (2024).
  • Per our database at Business Quant, Evoke Pharma's Non-Current Assets tumbled by 9189.07% in 2021 and then soared by 93857.42% in 2022.
  • Over the past 5 years, Evoke Pharma's Non-Current Assets (Quarter) stood at $12428.0 in 2021, then skyrocketed by 938.57% to $129074.0 in 2022, then skyrocketed by 87.21% to $241637.0 in 2023, then rose by 16.34% to $281110.0 in 2024, then tumbled by 59.79% to $113026.0 in 2025.
  • Its last three reported values are $113026.0 in Q3 2025, $129250.0 for Q2 2025, and $145070.0 during Q1 2025.